A Novel Composite Endpoint of Toxicity-Free, Progression-Free Survival (TPFS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Large B-Cell LymphomaAditi Saha,Razan Mohty,Junmin Whiting, Kristen Flores,Jongphil Kim,Taiga Nishihori,Julio C. Chavez,Farhad Khimani,Doris K. Hansen,Fabiana Perna,Hien Liu,Bijal D. Shah,Marian Dam,Muhammad Jaffer,Sepideh Mokhtari,Hany Elmariah,Rawan Faramand,Christina A. Bachmeier,Nelli Bejanyan,Frederick L. Locke,Michael D. Jain,Aleksandr LazaryanBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要